These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4320903)

  • 21. [Use of delayed-action Cortrosyn (Tetracosactide) in rheumatology. Apropos of 32 cases].
    Lièvre JA; Guillien P
    Brux Med; 1970 Dec; 50(12):1103-12. PubMed ID: 4322894
    [No Abstract]   [Full Text] [Related]  

  • 22. The present status of corticotrophin therapy.
    Malone DN; Strong JA
    Practitioner; 1972 Mar; 208(245):329-37. PubMed ID: 4337178
    [No Abstract]   [Full Text] [Related]  

  • 23. Synacthen depot.
    Drug Ther Bull; 1969 Jan; 7(1):4. PubMed ID: 4302906
    [No Abstract]   [Full Text] [Related]  

  • 24. Stabilization of a sustained release-type injection vehicle for a synthetic corticotrophin analogue.
    Futaguchi S; Odaguchi K; Tanaka A; Hirata M
    J Pharm Pharmacol; 1982 May; 34(5):343-4. PubMed ID: 6123581
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synacthen-depot in dermatology (author's transl)].
    Dubois-Ferrière G; Hunziker N; Orusco M
    Dermatologica; 1974; 148(2):65-71. PubMed ID: 4366321
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot].
    Hayakawa M
    Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical and hormonal evaluation of the corticotropic effect of delayed-action beta 1-24 tetracosapeptide].
    Strumia E; Bellucci Sessa M; Molinatti GM
    Minerva Med; 1970 Jan; 61(1):10-8. PubMed ID: 4324570
    [No Abstract]   [Full Text] [Related]  

  • 28. [Melanoderma as a side effect of cortisone depot therapy].
    Rainova R; Kaloianov K
    Vutr Boles; 1974; 13(2):120-2. PubMed ID: 4370659
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cortrosyn depot for treatment of asthmatic children].
    Schook JE; Schüller CF
    Ned Tijdschr Geneeskd; 1971 Aug; 115(34):1409-13. PubMed ID: 4327521
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of (L-Phe7) and (D-Phe7) ACTH 4-7 and an ACTH 4-7 analog with prolonged action on acetylcholinesterase activity in the rat brain].
    Aleksidze NG; Balavadze MV; Ponomareva-Stepnaia MA; Nezavibat'ko VN; Alferova LIu
    Biull Eksp Biol Med; 1983 Jul; 96(7):24-6. PubMed ID: 6307421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of obstructive bronchopathies with long-acting tetracosactide (synthetic corticostimuline)].
    Uzzan D; Chebat J; Olliero H; Israel-Asselain
    Presse Med (1893); 1969 Oct; 77(42):1485-6. PubMed ID: 4310565
    [No Abstract]   [Full Text] [Related]  

  • 32. [Soviet corticotropin in the treatment of neurodermatitis and eczema].
    Korotkiĭ NG; Eletskiĭ Aiu ; Udzhukhu VIu; Sharapova GIa; Zeĭni SM
    Vestn Dermatol Venerol; 1981 Aug; (8):55-8. PubMed ID: 6269321
    [No Abstract]   [Full Text] [Related]  

  • 33. Corticotrophin zinc phosphate and hydroxide; long-acting aqueous preparations.
    HOMAN JD; NEUTELINGS JP; OVERBEEK GA; BOOIJ CJ; VAN DER VIES J
    Lancet; 1954 Mar; 266(6811):541-3. PubMed ID: 13143722
    [No Abstract]   [Full Text] [Related]  

  • 34. [Determination of ACTH activity of different units].
    Kemaĭkina NG; Meerov GI
    Farmatsiia; 1970; 19(4):61-2. PubMed ID: 4321177
    [No Abstract]   [Full Text] [Related]  

  • 35. [MSH-like effect of synthetic corticotropins in man].
    Santoianni P; Berruti G
    G Ital Dermatol Minerva Dermatol; 1971 Aug; 46(8):346-9. PubMed ID: 4329818
    [No Abstract]   [Full Text] [Related]  

  • 36. [A new local corticosteroid in dermatology].
    Hanke E
    Ther Ggw; 1969 Jun; 108(6):868-70 passim. PubMed ID: 5383168
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of synthetic ACTH in the therapy of dermatologic diseases].
    Schuppli R
    Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigations on long-acting corticotrophin.
    PIT AA; CATS A; KASSENAAR AA
    Br Med J; 1954 Jan; 1(4852):29. PubMed ID: 13106459
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of gout attacks with synthetic delayed-action ACTH].
    Muzzolini M; Rosetto G; Compagnoni A
    Policlinico Med; 1970; 77(6):322-32. PubMed ID: 4331713
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preliminary observations concerning the use of a synthetic delayed-action corticostimulin derivative (CIBA 36.716-Ba) in patients with asthma].
    Buytendijk HJ; Maesen F
    Acta Tuberc Pneumol Belg; 1965; 56(3):234-43. PubMed ID: 4285039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.